KUALA LUMPUR, Jan 7 (Bernama) -- Biocon Biologics is committed to implementing business expansion in Malaysia. Biocon Biologics is a global company with capabilities in the development, manufacturing ...

New Delhi, Jan 25 (PTI) Biotechnology major Biocon has bagged a MYR 300 million (about Rs 460.5 crore) contract from the Ministry of Health, Malaysia to supply recombinant human insulin formulations f ...

Biocon will distribute insulins and insulin delivery devices through Malaysia’s CCM Pharmaceuticals. Shares of Biocon were trading 2.79 per cent higher at Rs 1,026.30 apiece on BSE.